Conduit Pharmaceuticals Inc.
CDT
$0.6201
-$0.16-20.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -86.90% | -98.24% | -- | 22,950.00% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 43.59% | -71.60% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -52.64% | -86.62% | -- | 39,350.00% | -- |
|
|
|||||
| Total Current Assets | -52.64% | -86.62% | -- | 39,350.00% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -21.19% | -20.25% | 26,600.00% | 28,200.00% | 29,720.00% |
| Total Assets | -41.96% | -75.10% | 66,000.00% | 37,723.08% | 144,380.00% |
|
|
|||||
| Total Accounts Payable | 564.19% | 5,314.29% | -- | -- | -- |
| Total Accrued Expenses | 226.62% | -51.63% | -82.18% | -69.60% | -76.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.53% | 148.52% | -- | -- | 462.86% |
| Total Finance Division Other Current Liabilities | -- | 728.84% | -- | 338.35% | -- |
| Total Other Current Liabilities | -- | 728.84% | -- | 338.35% | -- |
| Total Current Liabilities | 496.39% | 160.20% | -55.07% | 105.76% | -56.87% |
|
|
|||||
| Total Current Liabilities | 496.39% | 160.20% | -55.07% | 105.76% | -56.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -97.65% | -99.72% | 34.56% | -97.05% | 44.01% |
| Total Liabilities | 43.03% | -7.54% | -43.12% | -36.03% | -23.91% |
|
|
|||||
| Common Stock & APIC | 109.89% | 52.37% | -- | -- | 173,750.00% |
| Retained Earnings | -157.55% | -104.12% | -31.07% | -14.87% | -4.91% |
| Treasury Stock & Other | 0.73% | -57.59% | 1,234.48% | -5.83% | -39.11% |
| Total Common Equity | -1,386.43% | -743.48% | 64.55% | 75.24% | 95.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1,386.43% | -743.48% | 64.55% | 75.24% | 95.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1,386.43% | -743.48% | 64.55% | 75.24% | 95.47% |
|
|
|||||